Access cutting-edge fatty liver disease treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access fatty liver disease specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fatty liver disease treatment provided free
The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic steatohepatitis \[NASH\]).
Sponsor: 89bio, Inc.
Check if you qualify for this fatty liver disease clinical trial in Tucson, AZ
If you're searching for fatty liver disease treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fatty liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.